ResMed Inc. (FRA:RME)

Market Cap	34.80B
Revenue (ttm)	4.38B
Net Income (ttm)	1.19B
Shares Out	n/a
EPS (ttm)	8.10
PE Ratio	29.18
Forward PE	25.32
Dividend	1.95 (0.82%)
Ex-Dividend Date	May 8, 2025

Volume	n/a
Average Volume	48
Open	232.80
Previous Close	241.00
Day's Range	232.80 - 232.80
52-Week Range	180.20 - 248.90
Beta	n/a
RSI	79.20
Earnings Date	Jul 31, 2025

About The Aaron's Company

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1989
• Employees: 9,980
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RME

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in CAD